Elevated serum levels of cyclo (His-Pro),an endogenous inhibitor of pituitary prolactin secretion,in systemic lupus erythematosus patients

Abstract

Cyclo (His-Pro) or CHP is a cyclic dipeptide that is known to elicit many biologic activities including inhibition of pituitary prolactin (PRL) secretion. PRL stimulates humoral and cell mediated immune responses and hyperprolactinemia has been found in a subset of systemic lupus erythematosus (SLE) patients in association with active disease. To explore whether CHP may play a role in SLE patients, we measured, CHP and PRL levels in sera of 21 SLE patients and 11 normal controls. The results of this study show significantly (P < 0.001) high levels of CHP in SLE compared to controls. However, there was no significant correlation between serum PRL and CHP levels in SLE patients (r = 0.027, P = 0.29). The increase in serum levels of CHP may be in an attempt to increase hypothalamic content of dopamine which in turn would decrease pituitary PRL synthesis in hyperprolactinemic SLE patients.

Keywords

cyclo (His-Pro)prolactin neuropeptides SLE

Get full access to this article

View all access options for this article.

References

Jara LJ et al. Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am J Med Sci J Rheumatol 1992; 303: 222—226.

Jara LJ , Lavalle C. , Espinoza LR Does prolactin have a role in the pathogenesis of systemic lupus erythematosus . 1992; 19: 1333-1336.

Lavalle C. et al. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol 1987; 14: 268—272.

Neidhart M. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in SLE and other CTD. J Rheumatol 1996; 23: 476-481.

Walker SE , Allen SH , Hoffman RW , McMurray RW Prolactin: a stimulator of disease activity in systemic lupus erythematosus . Lupus 1995; 4: 3—9.

Athreya BH et al. Adenohypophyseal and sex hormones in pediatric rheumatic diseases . J Rheumatol 1993; 20: 725-730.

Gutierrez et al. Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity. Lupus 1995; 4: 348-352.

Sabharwal P. et al. Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor lymphoproliferation . Proc Natl Acad Sci USA 1992; 89: 7713-7716.

Montgomery DW et al. Identification of prolactin-like proteins synthesized by normal murine lymphocytes. Endocrinology 1992; 131: 3019-3026.

10.

Montgomery DW et al. Human thymocytes express a prolactin-like messenger ribonucleic acid and synthesize bioactive prolactin-like proteins . Endocrinology 1992; 131: 3019-3026.

11.

Prasad C. Bioactive cyclic depeptides. Peptides 1995 ; 16: 151-164.

12.

Tan EM et al. The 1982 revised criteria for classification of systemic lupus erythematosus (SLE). Arthritis Rheum 1982; 25: 1271-1277.

13.

Mori M. , Prasad C. , and Wilber JF Specific radioimmunoassay of cyclo (His-Pro), a biologically active metabolite of thyrotropin-releasing hormone. Endocrinology 1981; 108: 1995-1997.

14.

Vance ML , Thorner MO Prolactin: hyperprolactinemic syndromes and management, In: DeGroot LJ (ed). Endocrinology, edn 2 W.B. Saunders Co.; Philadelphia, 1989; pp 408.

15.

Prasad C. Cyclo (His-Pro): its distribution, origin and function in the human. Neurosci Biobehavioral Rev 1988; 12: 19—22.

16.

Prasad C. , Hilton CW , Lohr JB , Robertson Hjf. Increased cerebrospinal fluid cyclo (His-Pro) content in schizophrenia. Neuropeptides 1991; 20: 187-190.

17.

Pekary A. et al. High of thyrotropin-releasing hormone precursor peptide immunoreactivity and binding substance occur in cerebrospinal fluid. Neuroendocrinology 1991; 53: 246—252.

18.

Iriuchijima T. et al. Thyrotropin-releasing hormone and cyclo (His-Pro)-like immunoreactivities in the cerebrospinal fluids of normal infants and adults, and patients with various neuropsychiatric and neurologic disorders . Life Sci 1987; 41: 2419—2428.

19.

Prasad C. Neurobiology of cyclo (His-Pro). Ann NY Acad Sci 1989; 553: 232—251.

20.

Shyr SW , Grosvenor SE Histidyl-proline-diketopiperazine (cyclo-His-Pro) inhibits the suckling-and domperidone-induced transformation of prolactin in the lactating rat. Endocrinology 1985; 117: 2170-2175.

21.

Jikihara H. et al. Intraventricular administration of CHP suppresses prolactin synthesis and secretion: A possible role of CHP as dopamine uptake blocker in rat hypothalamus. Endocrinology 1993; 132: 953-958.

22.

McMurray RW , Weindensaul D. , Allen SH , Walker SE Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Rheumatol 1995; 22: 2084-2091 .